Page 296

use disorders and mental health conditions, as well as persons who 1 represent the unique needs of rural communities. 2 (a) The work group membership shall consist of, but is not 3 limited to, members appointed by the governor representing the 4 following: 5 (i) At least one adult in recovery from substance use disorder; 6 (ii) At least one youth in recovery from substance use disorder; 7 (iii) One expert from the addictions, drug, and alcohol institute 8 at the University of Washington; 9 (iv) One outreach services provider; 10 (v) One substance use disorder treatment provider; 11 (vi) One peer recovery services provider; 12 (vii) One recovery housing provider; 13 (viii) One expert in serving persons with co-occurring substance 14 use disorders and mental health conditions; 15 (ix) One expert in antiracism and equity in health care delivery 16 systems; 17 (x) One employee who provides substance use disorder treatment or 18 services as a member of a labor union representing workers in the 19 behavioral health field; 20 (xi) One representative of the association of Washington 21 healthcare plans; 22 (xii) One representative of sheriffs and police chiefs; 23 (xiii) One representative of a federally recognized tribe; and 24 (xiv) One representative of local government. 25 (b) The work group's evaluation shall include, but is not limited 26 to, the following: 27 (i) Examining the concept of "safe supply," defined as a legal 28 and regulated supply of mind or body altering substances that 29 traditionally only have been accessible through illicit markets; 30 (ii) Examining whether there is evidence that a proposed "safe 31 supply" would have an impact on fatal or nonfatal overdose, drug 32 diversion, or associated health and community impacts; 33 (iii) Examining whether there is evidence that a proposed "safe 34 supply" would be accompanied by increased risks to individuals, the 35 community, or other entities or jurisdictions; 36 (iv) Examining historical evidence regarding the overprescribing 37 of opioids; and 38 (v) Examining whether there is evidence that a proposed "safe 39 supply" would be accompanied by any other benefits or consequences. 40 p. 295 ESSB 5187.SL